ACHILLION PHARMACEUTICALS INC Proceeds from Common Stock Issued
ACHILLION PHARMACEUTICALS INC reported Proceeds from Common Stock Issued of $297.14 million for the 9-month period ending 2015-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2016-11-03
- ACHILLION PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2015-09-30 was $158.88M.
- ACHILLION PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2015-06-30 was -$31.00K.
- ACHILLION PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2015-03-31 was $138.29M.
- ACHILLION PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2013-12-31 was $0.00.
- ACHILLION PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2014 was $42.70M, a 67.94% decline from fiscal 2013.
- ACHILLION PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2013 was $133.21M, a 219.76% increase from fiscal 2012.
- ACHILLION PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2012 was $41.66M, a 31.65% decline from fiscal 2011.
- ACHILLION PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2011 was $60.95M, a 16.01% decline from fiscal 2010.
| Period end | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2015-09-30 | $158.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $158.85M derived: sum of 2 quarters · filed 2016-11-03 | $297.14M 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | -$31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $138.26M 10-Q · filed 2016-08-04 | |||
| 2015-03-31 | $138.29M 10-Q · filed 2016-05-03 | ||||
| 2014-12-31 | $42.70M 10-K · filed 2015-03-05 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-05 | $0.00 derived: sum of 2 quarters · filed 2015-03-05 | $0.00 derived: sum of 3 quarters · filed 2015-03-05 | $133.21M 10-K · filed 2015-03-05 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $0.00 derived: sum of 2 quarters · filed 2014-11-04 | $133.21M 10-Q · filed 2014-11-04 | $133.19M derived: sum of 4 quarters · filed 2015-03-05 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $133.21M 10-Q · filed 2014-08-07 | $133.19M derived: sum of 3 quarters · filed 2015-03-05 | ||
| 2013-03-31 | $133.21M 10-Q · filed 2014-05-07 | $133.19M derived: sum of 2 quarters · filed 2015-03-05 | |||
| 2013-02-28 | $133.21M 10-Q · filed 2013-11-12 | ||||
| 2012-12-31 | -$22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-05 | $41.66M 10-K · filed 2015-03-05 | |||
| 2012-09-30 | $41.68M 10-Q · filed 2013-11-12 | ||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$13.00K derived: sum of 2 quarters · filed 2014-03-07 | $60.95M 10-K · filed 2014-03-07 | ||
| 2011-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $60.95M 10-Q · filed 2012-11-08 | |||
| 2011-06-30 | $60.95M 10-K · filed 2013-02-20 | $60.96M 10-Q · filed 2012-08-08 | |||
| 2010-12-31 | $72.56M 10-K · filed 2013-02-20 | ||||
| 2010-02-28 | $22.63M 10-K · filed 2013-02-20 |